Cargando…

Ensemble learning based on efficient features combination can predict the outcome of recurrence-free survival in patients with hepatocellular carcinoma within three years after surgery

Preoperative prediction of recurrence outcome in hepatocellular carcinoma (HCC) facilitates physicians’ clinical decision-making. Preoperative imaging and related clinical baseline data of patients are valuable for evaluating prognosis. With the widespread application of machine learning techniques,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Liyang, Wu, Meilong, Zhu, Chengzhan, Li, Rui, Bao, Shiyun, Yang, Shizhong, Dong, Jiahong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686395/
https://www.ncbi.nlm.nih.gov/pubmed/36439437
http://dx.doi.org/10.3389/fonc.2022.1019009
_version_ 1784835737469845504
author Wang, Liyang
Wu, Meilong
Zhu, Chengzhan
Li, Rui
Bao, Shiyun
Yang, Shizhong
Dong, Jiahong
author_facet Wang, Liyang
Wu, Meilong
Zhu, Chengzhan
Li, Rui
Bao, Shiyun
Yang, Shizhong
Dong, Jiahong
author_sort Wang, Liyang
collection PubMed
description Preoperative prediction of recurrence outcome in hepatocellular carcinoma (HCC) facilitates physicians’ clinical decision-making. Preoperative imaging and related clinical baseline data of patients are valuable for evaluating prognosis. With the widespread application of machine learning techniques, the present study proposed the ensemble learning method based on efficient feature representations to predict recurrence outcomes within three years after surgery. Radiomics features during arterial phase (AP) and clinical data were selected for training the ensemble models. In order to improve the efficiency of the process, the lesion area was automatically segmented by 3D U-Net. It was found that the mIoU of the segmentation model was 0.8874, and the Light Gradient Boosting Machine (LightGBM) was the most superior, with an average accuracy of 0.7600, a recall of 0.7673, a F(1) score of 0.7553, and an AUC of 0.8338 when inputting radiomics features during AP and clinical baseline indicators. Studies have shown that the proposed strategy can relatively accurately predict the recurrence outcome within three years, which is helpful for physicians to evaluate individual patients before surgery.
format Online
Article
Text
id pubmed-9686395
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96863952022-11-25 Ensemble learning based on efficient features combination can predict the outcome of recurrence-free survival in patients with hepatocellular carcinoma within three years after surgery Wang, Liyang Wu, Meilong Zhu, Chengzhan Li, Rui Bao, Shiyun Yang, Shizhong Dong, Jiahong Front Oncol Oncology Preoperative prediction of recurrence outcome in hepatocellular carcinoma (HCC) facilitates physicians’ clinical decision-making. Preoperative imaging and related clinical baseline data of patients are valuable for evaluating prognosis. With the widespread application of machine learning techniques, the present study proposed the ensemble learning method based on efficient feature representations to predict recurrence outcomes within three years after surgery. Radiomics features during arterial phase (AP) and clinical data were selected for training the ensemble models. In order to improve the efficiency of the process, the lesion area was automatically segmented by 3D U-Net. It was found that the mIoU of the segmentation model was 0.8874, and the Light Gradient Boosting Machine (LightGBM) was the most superior, with an average accuracy of 0.7600, a recall of 0.7673, a F(1) score of 0.7553, and an AUC of 0.8338 when inputting radiomics features during AP and clinical baseline indicators. Studies have shown that the proposed strategy can relatively accurately predict the recurrence outcome within three years, which is helpful for physicians to evaluate individual patients before surgery. Frontiers Media S.A. 2022-11-10 /pmc/articles/PMC9686395/ /pubmed/36439437 http://dx.doi.org/10.3389/fonc.2022.1019009 Text en Copyright © 2022 Wang, Wu, Zhu, Li, Bao, Yang and Dong https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Wang, Liyang
Wu, Meilong
Zhu, Chengzhan
Li, Rui
Bao, Shiyun
Yang, Shizhong
Dong, Jiahong
Ensemble learning based on efficient features combination can predict the outcome of recurrence-free survival in patients with hepatocellular carcinoma within three years after surgery
title Ensemble learning based on efficient features combination can predict the outcome of recurrence-free survival in patients with hepatocellular carcinoma within three years after surgery
title_full Ensemble learning based on efficient features combination can predict the outcome of recurrence-free survival in patients with hepatocellular carcinoma within three years after surgery
title_fullStr Ensemble learning based on efficient features combination can predict the outcome of recurrence-free survival in patients with hepatocellular carcinoma within three years after surgery
title_full_unstemmed Ensemble learning based on efficient features combination can predict the outcome of recurrence-free survival in patients with hepatocellular carcinoma within three years after surgery
title_short Ensemble learning based on efficient features combination can predict the outcome of recurrence-free survival in patients with hepatocellular carcinoma within three years after surgery
title_sort ensemble learning based on efficient features combination can predict the outcome of recurrence-free survival in patients with hepatocellular carcinoma within three years after surgery
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686395/
https://www.ncbi.nlm.nih.gov/pubmed/36439437
http://dx.doi.org/10.3389/fonc.2022.1019009
work_keys_str_mv AT wangliyang ensemblelearningbasedonefficientfeaturescombinationcanpredicttheoutcomeofrecurrencefreesurvivalinpatientswithhepatocellularcarcinomawithinthreeyearsaftersurgery
AT wumeilong ensemblelearningbasedonefficientfeaturescombinationcanpredicttheoutcomeofrecurrencefreesurvivalinpatientswithhepatocellularcarcinomawithinthreeyearsaftersurgery
AT zhuchengzhan ensemblelearningbasedonefficientfeaturescombinationcanpredicttheoutcomeofrecurrencefreesurvivalinpatientswithhepatocellularcarcinomawithinthreeyearsaftersurgery
AT lirui ensemblelearningbasedonefficientfeaturescombinationcanpredicttheoutcomeofrecurrencefreesurvivalinpatientswithhepatocellularcarcinomawithinthreeyearsaftersurgery
AT baoshiyun ensemblelearningbasedonefficientfeaturescombinationcanpredicttheoutcomeofrecurrencefreesurvivalinpatientswithhepatocellularcarcinomawithinthreeyearsaftersurgery
AT yangshizhong ensemblelearningbasedonefficientfeaturescombinationcanpredicttheoutcomeofrecurrencefreesurvivalinpatientswithhepatocellularcarcinomawithinthreeyearsaftersurgery
AT dongjiahong ensemblelearningbasedonefficientfeaturescombinationcanpredicttheoutcomeofrecurrencefreesurvivalinpatientswithhepatocellularcarcinomawithinthreeyearsaftersurgery